Millrace Asset Group, Inc. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 300 filers reported holding HAEMONETICS CORP in Q4 2019. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
Millrace Asset Group, Inc. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$1,726
-2.1%
19,264
-7.0%
2.13%
+15.4%
Q2 2023$1,763
-99.8%
20,706
+109.7%
1.85%
+24.3%
Q1 2020$984,000
-41.6%
9,872
-32.7%
1.49%
-18.9%
Q4 2019$1,685,000
+17.2%
14,665
+28.6%
1.83%
+8.7%
Q3 2019$1,438,000
+32.8%
11,400
+26.7%
1.69%
+50.5%
Q2 2019$1,083,0009,0001.12%
Other shareholders
HAEMONETICS CORP shareholders Q4 2019
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders